Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure.

Journal Article (Clinical Trial;Journal Article;Multicenter Study)

The most common form of neurologic injury in sickle cell anemia (SCA) is silent cerebral infarction (SCI). In the Silent Cerebral Infarct Multi-Center Clinical Trial, we sought to identify risk factors associated with SCI. In this cross-sectional study, we evaluated the clinical history and baseline laboratory values and performed magnetic resonance imaging of the brain in participants with SCA (HbSS or HbSβ° thalassemia) between the ages of 5 and 15 years with no history of overt stroke or seizures. Neuroradiology and neurology committees adjudicated the presence of SCI. SCIs were diagnosed in 30.8% (251 of 814) participants who completed all evaluations and had valid data on all prespecified demographic and clinical covariates. The mean age of the participants was 9.1 years, with 413 males (50.7%). In a multivariable logistic regression analysis, lower baseline hemoglobin concentration (P < .001), higher baseline systolic blood pressure (P = .018), and male sex (P = .030) were statistically significantly associated with an increased risk of an SCI. Hemoglobin concentration and systolic blood pressure are risk factors for SCI in children with SCA and may be therapeutic targets for decreasing the risk of SCI. This study is registered at as #NCT00072761.

Full Text

Duke Authors

Cited Authors

  • DeBaun, MR; Sarnaik, SA; Rodeghier, MJ; Minniti, CP; Howard, TH; Iyer, RV; Inusa, B; Telfer, PT; Kirby-Allen, M; Quinn, CT; Bernaudin, F; Airewele, G; Woods, GM; Panepinto, JA; Fuh, B; Kwiatkowski, JK; King, AA; Rhodes, MM; Thompson, AA; Heiny, ME; Redding-Lallinger, RC; Kirkham, FJ; Sabio, H; Gonzalez, CE; Saccente, SL; Kalinyak, KA; Strouse, JJ; Fixler, JM; Gordon, MO; Miller, JP; Noetzel, MJ; Ichord, RN; Casella, JF

Published Date

  • April 19, 2012

Published In

Volume / Issue

  • 119 / 16

Start / End Page

  • 3684 - 3690

PubMed ID

  • 22096242

Pubmed Central ID

  • PMC3335377

Electronic International Standard Serial Number (EISSN)

  • 1528-0020

Digital Object Identifier (DOI)

  • 10.1182/blood-2011-05-349621


  • eng

Conference Location

  • United States